08:39 AM EDT, 07/22/2025 (MT Newswires) -- Pacira Biosciences ( PCRX ) said Tuesday it is collaborating with Johnson & Johnson's ( JNJ ) Johnson & Johnson Medtech to expand the market reach of Zilretta, Pacira's extended-release injectable treatment for osteoarthritis knee pain.

Pacira said the partnership is expected to expand patient access and extend Zilretta's reach into more physician specialties, including sports medicine, pain management and rheumatology, on top of orthopedic practices.